Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

VYNE

VYNE Therapeutics (VYNE)

VYNE Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:VYNE
FechaHoraFuenteTítuloSímboloCompañía
09/05/202415:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
09/05/202407:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
01/03/202416:16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
01/03/202416:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
02/02/202408:42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
03/01/202416:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202416:01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
23/11/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:VYNEVYNE Therapeutics Inc
22/11/202315:07Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:VYNEVYNE Therapeutics Inc
16/11/202315:30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202315:03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202315:01Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYNEVYNE Therapeutics Inc
13/11/202314:59Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYNEVYNE Therapeutics Inc
02/06/202315:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202315:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VYNEVYNE Therapeutics Inc
11/05/202315:22Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VYNEVYNE Therapeutics Inc
14/03/202316:14Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VYNEVYNE Therapeutics Inc
10/01/202307:45AllPennyStocks.comBiotech Catches Major Premarket BidNASDAQ:VYNEVYNE Therapeutics Inc
25/11/202213:01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:VYNEVYNE Therapeutics Inc
18/11/202216:01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:VYNEVYNE Therapeutics Inc
14/11/202215:51Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:VYNEVYNE Therapeutics Inc
11/11/202205:25TipRanksVYNE Therapeutics (VYNE) Gets a Buy from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
10/08/202209:10TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and MiNK Therapeutics (INKT)NASDAQ:VYNEVYNE Therapeutics Inc
28/07/202215:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VYNEVYNE Therapeutics Inc
21/06/202204:06TipRanksLifeSci Capital Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
19/06/202202:50TipRanksVYNE Therapeutics (VYNE) Gets a Buy Rating from H.C. WainwrightNASDAQ:VYNEVYNE Therapeutics Inc
24/05/202203:15TipRanksAnalysts Offer Insights on Healthcare Companies: VYNE Therapeutics (VYNE) and Nano-X Imaging (NNOX)NASDAQ:VYNEVYNE Therapeutics Inc
20/05/202204:01TipRanksAnalysts Offer Insights on Healthcare Companies: and VYNE Therapeutics (VYNE)NASDAQ:VYNEVYNE Therapeutics Inc
18/05/202205:18TipRanksH.C. Wainwright Thinks VYNE Therapeutics’ Stock is Going to RecoverNASDAQ:VYNEVYNE Therapeutics Inc
12/05/202216:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:VYNEVYNE Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYNE